all report title image
  • Published On : Jan 2019
  • Code : CMI2451
  • Industry : Medical Devices
  • Pages : 160
  • Formats :

Global Sinus Dilation Devices Market

Sinus dilation devices play a major role in modern healthcare, allowing the sinus openings to expand during nasal sinusitis and are preferred over antibiotics, decongestants, or steroids, as it provides long-lasting and immediate results.

The global sinus dilation devices market was valued at US$ 2.7 billion in 2017, and is expected to exhibit a CAGR of 8.4% over the forecast period (2018 – 2026).

Figure 1. Global Sinus Dilation devices Market Value (US$ Mn), by Region, 2017

sinus dilation devices market fig1

Source: Coherent Market Insights Analysis (2018)

Increasing prevalence of chronic sinusitis is expected to propel growth of the sinus dilation devices market

Sinus dilation device is used in nasal sinusitis and nose drainage issues. High prevalence of chronic sinusitis is expected to propel demand for of sinus dilation devices, which in turn is expected to drive the market growth. According to the Centers for Disease Control and Prevention (CDC), in 2016, around 26.7 million adults in the U.S. were diagnosed with chronic sinusitis. Chronic sinusitis affects 146 per 1000 people in the U.S., while in Canada the estimated prevalence of diagnosed chronic sinusitis is around 2% to 2.5% of the population. Sinusitis results in over 18-22 million physician visits per year in the U.S. The socioeconomic burden is valued at US$ 3.4-5 billion annually, for the treatment of this chronic sinusitis.

Furthermore, according to the study published in the U.S. National Library of Medicine, up to 64% of the patients suffering from acquired immune deficiency syndrome (AIDS) have possibility to develop chronic sinusitis in their course of life.

However, complications such as excessive and prolonged bleeding, post-surgical infections, which can be life threatening such as Methicillin-Resistant Staphylococcus Aureus (MRSA), and rare complications such as cerebrospinal fluid rhinorrhea are expected to limit adoption of sinus dilation devices, thereby hindering the market growth.

A study conducted by American Journal of Rhinology & Allergy in 2014, suggested that the complication rate for balloon sinuoplasty (BSP) was 5.26% and it was 7.35% for conventional functional endoscopic sinus surgery (FESS). Major complications associated with the endoscopic surgeries are due to balloon sinuplasty

Figure 2. Global Sinus Dilation Devices Market Share (%), by Design, 2018 and 2026

sinus dilation devices market fig2

Source: Coherent Market Insights Analysis (2018)

Increasing adoption of sinus dilation devices in North America is expected to boost growth of the market

North America holds dominant position in the global sinus dilation devices market, owing to high availability of sinus dilation devices in medical settings. Medications such as antibiotics and topical steroids help to open up blocked sinus passages and relieve symptoms. However, these medicines serve as short-term relive and do not fix the condition permanently, therefore, many people in the U.S. are adopting surgical methods for the treatment of this condition. According to the research published in the National Center for Biotechnology Information (NCBI), over 600,000 ambulatory sinonasal cases are performed each year in the U.S.

One of the minimally invasive and most favorable technique is Balloon Sinus Dilation (BSD). The balloon sinus dilation opens inflamed sinuses restoring normal sinus drainage and function often without tissue or bone removal. According to Entellus Inc.’s annual report, around 552,000 patients underwent FESS procedures in the U.S. in 2015. Out of which, over 55% were well suited for balloon sinus dilation, and the supplementary 30% were apt for hybrid balloon sinus dilation (BSD with FESS).

Key Players

Major players operating in the global sinus dilation devices market include, Entellus Medical, Inc., Smith & Nephew Plc., Acclarent, Inc., B. Braun Melsungen AG, Medtronic Plc, Olympus Corporation, SinuSys Corporation, InnAccel Technologies, and Intersect ENT, Inc.

Sinusitis is an inflammation of sinus, which causes nose blockage and avoids mucus drainage. Sinus dilation devices are used in patients with nose drainage issues related to nasal sinusitis or sinuses to expand the sinus openings. Different types of sinus dilation devices can be utilized for patients according to the need of the treatment, which includes balloon sinuplasty systems, rhinoscopes, sinus stents, and functional endoscopic sinus surgery (FESS), and instruments set for sinuses or sinusitis. During balloon sinus dilation procedure, doctor reshapes the patient's sinus pathway with inflated balloons to open the blocked sinus or nasal pathway. Sinus dilation procedures are generally preferred over antibiotics, decongestants, or steroids, as it provides long-lasting and immediate results.

Market Dynamics

Factors driving the sinus dilation devices market are increasing prevalence of chronic sinusitis, growing preference for minimally invasive surgeries, and favorable reimbursement scenario of surgical treatments for hospital outpatient department. According to the Centers for Disease Control and Prevention (CDC), in 2016, around 26.7 million adults in the U.S. were diagnosed with chronic sinusitis. According to National Center for Biotechnology Information (NCBI), over 600,000 ambulatory sinonasal cases are performed each year in the U.S.  Centers for Medicare Services (CMS) reassigned the nasal/sinus endoscopy codes, for instance, sphenoid balloon dilation (31297) and maxillary FESS procedures (31267) were reassigned to higher paying Ambulatory Payment Classifications (APCs). This resulted in a significant payment increase of 52.6%, which increased reimbursed cost of both the endoscopic sinus surgeries from US$ 2,009 in 2015 to US$ 3,066 in 2016.

Furthermore, increasing number of product launches and FDA approvals are expected to drive the market growth.

Key features of the study:

  • This report provides in-depth analysis of the sinus dilation devices market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global sinus dilation devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Entellus Medical, Inc., Smith & Nephew Plc., Acclarent, Inc., B. Braun Melsungen AG, Medtronic Plc, Olympus Corporation, SinuSys Corporation, InnAccel Technologies, Intersect ENT, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global sinus dilation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the sinus dilation devices market

Detailed Segmentation:

  • Global Sinus Dilation devices Market, By Product Type:
    • Balloon Sinuplasty Systems
    • Rhinoscopes
    • Sinuscopes
    • Sinus Stents
    • Functional Endoscopic Sinus Surgery (FESS) Instruments Set
    • Others
  • Global Sinus Dilation devices Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers (ASCs)
  • Global Sinus Dilation devices Market, By Geography:
    • North America
      • By Product Type:
        • Balloon Sinuplasty Systems
        • Rhinoscopes
        • Sinuscopes
        • Sinus Stents
        • Functional Endoscopic Sinus Surgery (FESS) Instruments Set
        • Others
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers (ASCs)
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Balloon Sinuplasty Systems
        • Rhinoscopes
        • Sinuscopes
        • Sinus Stents
        • Functional Endoscopic Sinus Surgery (FESS) Instruments Set
        • Others
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers (ASCs)
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Balloon Sinuplasty Systems
        • Rhinoscopes
        • Sinuscopes
        • Sinus Stents
        • Functional Endoscopic Sinus Surgery (FESS) Instruments Set
        • Others
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers (ASCs)
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Balloon Sinuplasty Systems
        • Rhinoscopes
        • Sinuscopes
        • Sinus Stents
        • Functional Endoscopic Sinus Surgery (FESS) Instruments Set
        • Others
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers (ASCs)
        • Specialty Clinics
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Balloon Sinuplasty Systems
        • Rhinoscopes
        • Sinuscopes
        • Sinus Stents
        • Functional Endoscopic Sinus Surgery (FESS) Instruments Set
        • Others
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers (ASCs)
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Balloon Sinuplasty Systems
        • Rhinoscopes
        • Sinuscopes
        • Sinus Stents
        • Functional Endoscopic Sinus Surgery (FESS) Instruments Set
        • Others
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers (ASCs)
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Entellus Medical, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Smith & Nephew Plc.
    • Acclarent, Inc.
    • Braun Melsungen AG
    • Medtronic Plc
    • Olympus Corporation
    • SinuSys Corporation
    • InnAccel Technologies
    • Intersect ENT, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global sinus dilation devices market is estimated to surpass US$ 5.7 Billion by 2026.
Major players operating in the global sinus dilation devices market include Entellus Medical, Inc., Smith & Nephew Plc., Acclarent, Inc., B. Braun Melsungen AG, Medtronic Plc, Olympus Corporation, SinuSys Corporation, InnAccel Technologies, and Intersect ENT, Inc.
Complications associated with sinus dilation devices such as excessive and prolonged bleeding, and post-surgical infections is one of the major factors that is expected to hamper growth of the market over the forecast period.
Increasing prevalence of chronic sinusitis is one of the major factors that is expected to propel growth of the market over the forecast period.
The global sinus dilation devices market is estimated to exhibit a CAGR of 8.4% over the forecast period (2018-2026).
Among product type, balloon sinuplasty systems segment held a dominant position in the sinus dilation devices market in 2017, owing to higher adoption rate for sinusitis treatment.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo